BridgeBio Pharma (BBIO) Shareholder's Equity (2017 - 2026)

BridgeBio Pharma (BBIO) Shareholder's Equity (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 BridgeBio Pharma 12.90 Bn 11.97 Bn 184.58 Mn -2.27 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.27 Bn
Dec 31, 2025 -2.09 Bn
Sep 30, 2025 -1.93 Bn
Jun 30, 2025 -1.78 Bn
Mar 31, 2025 -1.64 Bn
Dec 31, 2024 -1.46 Bn
Sep 30, 2024 -1.22 Bn
Jun 30, 2024 -1.08 Bn
Mar 31, 2024 -1.04 Bn
Dec 31, 2023 -1.34 Bn
Sep 30, 2023 -1.20 Bn
Jun 30, 2023 -1.35 Bn
Mar 31, 2023 -1.21 Bn
Dec 31, 2022 -1.24 Bn
Sep 30, 2022 -1.13 Bn
Jun 30, 2022 -1.01 Bn
Mar 31, 2022 -1.04 Bn
Dec 31, 2021 -867.00 Mn
Sep 30, 2021 -738.84 Mn
Jun 30, 2021 -457.49 Mn